ASCO 2022 | Addressing disparities seen in care between black and white patients with DLBCL

Name: Addressing disparities seen in care between black and white patients with DLBCL
Uploaded: 2022-06-04T00:00:00Z
Duration: 45 s
Description: Daniel Arthur Ermann, MD, Huntsman Cancer Institute, University of Utah, UT, discusses strategies to address healthcare disparities seen in care between black and white patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Daniel Arthur Ermann • 4 Jun 2022

ASCO 2022

Diffuse Large B-Cell Lymphoma Non-Hodgkin Lymphoma

Daniel Arthur Ermann, MD, Huntsman Cancer Institute, University of Utah, UT, discusses strategies to address healthcare disparities seen in care between black and white patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.